Brian Lee has transformed the science of linking prenatal experiences to a child’s chances of having autism; his work taps social skills as well as statistical acumen.
The possibility of microbial treatments for autism has inspired a burst of research and nascent clinical trials, but new research suggests these efforts rest on shaky scientific ground.
Common and rare variants in or near autism-associated genes can have opposite effects on cognition.
Fallout over two recent studies highlights the potential power of social media to shape science, and the shifting dynamics between researchers and the autistic community.
In this week’s Community Newsletter, we look at a new proof for a method to understand how social interactions are organized and a philosophical thread on polygenic risk scores for autism and intellectual disability.
Those who no longer wish to attend the virtual meeting of the Society for Neuroscience (SfN) can request registration fee refunds, SfN announced after a social media outcry.
In this week’s Community Newsletter, we look at a study that tapped Twitter for insight on autistic burnout, a commentary on giving resting-state research a rest and some reassurance for early-career researchers on how long it takes to publish new work.
The decision comes after a Spectrum survey found that most autism researchers did not plan to attend in person.
After imposing a pause in November 2020, the U.S. Food and Drug Administration has cleared the way for a clinical trial of a gene therapy for Angelman syndrome.
Autistic children from low-income families are diagnosed about eight months later than their wealthier peers, a new analysis of insurance claims in Virginia shows.
A drug that helps promote gene expression reduces repetitive behaviors and improves memory and sociability in a mouse model of autism.
